HCA Healthcare (NYSE:HCA – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.
Insider & Institutional Ownership
62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by insiders. Comparatively, 0.4% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares HCA Healthcare and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| HCA Healthcare | 8.77% | -244.79% | 11.10% |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
Volatility and Risk
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for HCA Healthcare and INVO Fertility, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| HCA Healthcare | 1 | 8 | 14 | 0 | 2.57 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
HCA Healthcare presently has a consensus target price of $462.64, suggesting a potential upside of 14.25%. INVO Fertility has a consensus target price of $20.00, suggesting a potential upside of 1,930.46%. Given INVO Fertility’s higher possible upside, analysts clearly believe INVO Fertility is more favorable than HCA Healthcare.
Valuation & Earnings
This table compares HCA Healthcare and INVO Fertility”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| HCA Healthcare | $75.60 billion | 1.16 | $6.78 billion | $29.87 | 13.56 |
| INVO Fertility | $6.84 million | 0.36 | -$25.13 million | ($33.83) | -0.03 |
HCA Healthcare has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.
Summary
HCA Healthcare beats INVO Fertility on 11 of the 15 factors compared between the two stocks.
About HCA Healthcare
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
